ProfessorDavidCarling

Bustraan S, Bennett J, Whilding C, et al.Bustraan S, Bennett J, Whilding C, Pennycook BR, Smith D, Barr AR, Read J, Carling D, Pollard A close, 2024, AMP-activated protein kinase activation suppresses leptin expression independently of adipogenesis in primary murine adipocytes., Biochem J, Vol:481, Pages:345-362

• DOI
• Author Web Link

Constantin TA, Varela-Carver A, Greenland KK, et al.Constantin TA, Varela-Carver A, Greenland KK, de Almeida GS, Olden E, Penfold L, Ang S, Ormrod A, Leach DA, Lai C-F, Ainscow EK, Bahl AK, Carling D, Fuchter MJ, Ali S, Bevan CL close, 2024, Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer., Br J Cancer, Vol:130

• DOI
• Author Web Link

McGlone ER, Siebert M, Dore M, et al.McGlone ER, Siebert M, Dore M, Hope DCD, Davies I, Owen B, Khoo B, Goldin R, Carling D, Bloom S, Le Gall M, Tan TM-M close, 2023, Sleeve gastrectomy causes weight-loss independent improvements in hepatic steatosis, Liver International, Vol:43, ISSN:1478-3223, Pages:1890-1900

• DOI
• Publisher Web Link
• Open Access Link

Constantin TA, Varela-Carver A, Greenland KK, et al.Constantin TA, Varela-Carver A, Greenland KK, de Almeida GS, Olden E, Penfold L, Ang S, Ormrod A, Leach DA, Lai C-F, Ainscow EK, Bahl AK, Carling D, Fuchter MJ, Ali S, Bevan CL close, 2023, The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer, British Journal of Cancer, Vol:128, ISSN:0007-0920, Pages:2326-2337

• DOI
• Publisher Web Link
• Open Access Link

Carling D, Bevan C, Leach D, et al.Carling D, Bevan C, Leach D, Fets L, Woods A, Pollard A, Whilding C, Penfold L, Navarro-Pascual E, Muckett P, Montoya A, Mokochinski J, Constantin T, Hall Z, Dore M, Nikitin Y close, 2023, AMPK activation protects against prostate cancer by inducing a catabolic cellular state, Cell Reports, Vol:42, ISSN:2211-1247, Pages:1-21

• DOI
• Publisher Web Link
• Open Access Link